Search results for: 'Cancer Cell Analysis'

Electrification in trucking is gaining momentum as a Mega Trend, with new mobility models shaping the industry s future. Various sub-trends within electric vehicles (EVs), such as battery EVs (BEVs) and FCEVs, are increasingly popular as emission norms become stricter and the focus on achieving cleaner forms of goods transportation is higher. The p...

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.

Global demand for electric vehicle (EV) batteries is surging, driven by the rapid growth of EVs and the increasingly stringent environmental regulations. In response, the industry is experiencing a transformative shift, with advancements in battery formats, chemistries, and structural designs. Cylindrical, prismatic, and pouch cells—each with uniqu...

Solar energy constituted 65% of the total 295 GW installed renewable capacity in 2022. About 70% of the deployed solar panels were monofacial panels that generate electricity from only the top side of the panel. Despite their popularity, these monofacial panels have encountered challenges related to space efficiency, energy yield, and dependence on...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

The global cancer survivorship care market has gained significance due to improvements in cancer treatment and the rising cancer survival rates. The availability of reimbursement policies in the United States favors the cancer survivorship care market in the country. Several health IT companies are considering the use of electronic health records (...

This research service evaluates the Western European cancer IVD market for Germany, the United Kingdom, Italy, Spain, France, Benelux and Scandinavia from 2010 to 2019. Beginning with an overview of the main market metrics and trends, the study identifies the key market drivers and restraints, evaluates ongoing competitive trends with detailed mark...